Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06)

1. Bellmunt, J.
2. Trigo, J.M.
3. Calvo, E.
4. Carles, J.
5. Pérez-Gracia, J.L.
6. Rubió, J.
7. Virizuela, J.A.
8. López, R.
9. Lázaro, M.
10. Albanell, J.